Skip to main content
. Author manuscript; available in PMC: 2018 Mar 1.
Published in final edited form as: HIV Clin Trials. 2017 Feb 17;18(2):75–82. doi: 10.1080/15284336.2017.1287536

Table 2.

Comparison of patient and clinical characteristics by final eligibility status among patients who were preliminarily eligible. (n=1,514)

Eligible
(N=781)
%
Ineligible
(n=733)
%
p-value
Age 0.49
   <30 11.1 11.9
   30–39 26.5 24.3
   40–49 37.3 35.7
   50–59 21.5 24.8
   60+ 3.6 3.3
Sex 0.02
   Male 74.4 68.9
   Female 25.6 31.1
Race/ethnicity 0.02
   Black (non-Hispanic) 62.7 60.9
   White (non-Hispanic) 12.2 16.6
   Hispanic 24.1 20.5
   Missing 1.0 2.1
Most recent CD4+ count (cells/uL)* 0.36
   <200 60.1 60.6
   200–500 23.5 25.5
   ≥500 16.4 13.9
Most recent viral load (copies/mL)** <0.01
   ≤400 22.8 29.5
   >400 77.2 70.5
*

Missing CD4+ count: n=129

**

Missing viral load: n=257

***

Patients not in care at TSHC could potentially be in care elsewhere